The United States Patent and Trademark Office (USPTO) has granted patent US12582729B2, titled 'Kit for producing and storing radiopharmaceuticals,' to Wake Forest University Health Sciences. The patent, filed on January 25, 2019, and granted on March 24, 2026, relates to radiopharmaceuticals with improved stability, specifically a kit and method for producing Zr-89-PET radiopharmaceuticals. This grant signifies the USPTO's recognition of novel technology in the field of radiopharmaceutical production and storage.

This patent grant is primarily an informational event for the pharmaceutical and healthcare sectors. While it does not impose new regulatory obligations or compliance deadlines on entities, it highlights advancements in radiopharmaceutical technology. Companies involved in the development, manufacturing, or clinical use of PET radiopharmaceuticals, particularly those utilizing Zr-89, should be aware of this patented technology. It may influence future research, development, and commercialization strategies in this specialized area of medical imaging and therapy.